期刊文献+

心房颤动的抗凝治疗

Antithrom botic therapy for atrial fibrillation
下载PDF
导出
作者 马长生 杜昕
出处 《实用药物与临床》 CAS 2005年第4期3-5,共3页 Practical Pharmacy and Clinical Remedies
  • 相关文献

参考文献20

  • 1马长生,周玉杰,马煜,郑知刚,颜红兵,王勇,李霄,柯元南,汤旦林.北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究[J].中华心血管病杂志,2002,30(3):165-167. 被引量:148
  • 2戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
  • 3Wattigney WA,Mensah GA,Croft JB.Increasing Trends in Hospitalization for Atrial Fibrillation in the United States,1985 Through 1999 Implications for Primary Prevention[J].Circulation,2003,108:711-716.
  • 4Petersen P.Thromboembolic complications in atrial fibrillation[J].Stroke,1990,21:4-13.
  • 5胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:361
  • 6Peterson P,Boysen G,Gotfriedsen J,et al.Placebo-controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.The Copenhagen AFASAK Study[J].Lancet,1989,1:175-179.
  • 7The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation.N Engl J Med[J].1990,323:1505-1511.
  • 8Stroke Prevention in Atrial Fibrillation Investigators.Stroke Prevention in Atrial Fibrillation Study: Final results[J].Circulation,1991,84:527-539.
  • 9Connolly SJ,Laupacis A,Gent M,et al.Canadian Atrial Fibrillation Anticoagulation (CAFA) Study[J].J Am Coll Cardiol ,1991,18:349-355.
  • 10Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonreumatic atrial fibrillation[J].N Engl J Med,1992,327:1406-1412.

二级参考文献10

  • 1Saoudi N,Schoels W,EL-Sherif N,eds.Atrial flutter and fibrillation:from basic to clinical applications[]..1998
  • 2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
  • 3Caro JJ,Flegel KM,Orejuela ME,et al.Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice[].Canadian Medical Association Journal.1999
  • 4Flegel KM,Shipley MJ,Rise G.Risk of stroke in non-rheumatic atrial fibrillation[].The Lancet.1987
  • 5Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation[].Stroke.2000
  • 6Hart RG,Sherman DG,Easton JD,et al.Prevention of stroke in patients with nonvalvular atrial fibrillation[].Neurology.1998
  • 7Peterson P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications on chronic atrial fibrillation: the Compenhagen AFASAK study[].The Lancet.1989
  • 8Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications[].Archives of Internal Medicine.1995
  • 9Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation:Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators[].The New England Journal of Medicine.1992
  • 10Connolly SJ,Laupacis A,Gent M,et al.Canadian atrial fibrillation anticoagulation (CAFA) study[].Journal of the American College of Cardiology.1991

共引文献762

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部